Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Aditya Birla Sun Life Mutual Fund · Equity · mandate: ≥80% in the named sector/theme · benchmark: —
AUM (all plans)
920 cr
TER direct / regular
1.01% / 2.27%
CAGR (full)
17.9%
Sharpe (full)
0.77
Sharpe (bull ≤Sep-24)
2.93
Sharpe (sideways Oct-24→)
0.17
Max drawdown
-17.4%
Months of data
85
Percentile ranks this fund within its peer pool; the leaderboard Score is
the weighted average of its fiscal-year percentiles (equity: active-return-rank blended
with IR-rank).
Equity curve
Drawdown
Fiscal-year record
FY
Return
vs category
Sharpe
months
FY22
14.8%
-6.3%
0.57
12
FY23
-8.9%
-12.2%
-1.29
12
FY24
63.9%
17.6%
3.08
12
FY25
12.6%
5.6%
0.39
12
FY26
4.0%
5.2%
-0.16
12
FY27*
21.3%
3.0%
5.53
5
Active/Fund returns are TOTALS over the months covered — never annualized
(FY27* is year-to-date; a * row covers only part of the year).
%ile is the fund's percentile within its peer pool for that year.
Monthly returns (%)
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Year
2019
+0.8
-1.2
+4.8
+1.5
+0.2
+6.2
2020
+4.8
-1.0
-9.6
+23.2
+1.0
+1.0
+11.2
+2.8
+7.0
-3.7
+5.5
+6.6
+56.6
2021
-4.0
-0.4
+3.0
+8.5
+4.5
+3.0
+3.2
+3.3
-1.3
-3.6
+0.7
+3.2
+21.4
2022
-7.7
-3.7
+4.8
-1.1
-7.1
-2.5
+5.3
-0.3
+1.4
+2.5
+1.3
-3.9
-11.3
2023
-2.6
-2.5
+0.9
+4.4
+2.3
+9.4
+8.4
+0.2
+3.6
-3.8
+10.7
+4.2
+39.6
2024
+7.3
+4.8
-0.1
-0.8
+0.1
+3.4
+11.3
+6.2
+1.6
-2.7
-1.8
+4.1
+37.7
2025
-7.6
-7.3
+7.5
+2.2
-0.4
+3.2
+3.4
-2.9
-1.6
+2.3
+1.0
-1.8
-3.1
2026
-3.0
+5.2
-3.2
+4.8
+4.6
+5.6
+4.6
+0.1
+19.8
Quarterly average AUM & estimated net flows
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by
construction). Monthly returns are month-end NAV chains; stale prints (>7 days before
month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla
direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified
against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic
monthly convention. Independence: all figures are computed from mandatory public disclosures with a
fixed methodology applied identically to every fund — no fund can pay for inclusion,
exclusion, placement, or altered presentation, and any material commercial relationship
will be disclosed on the affected pages.
Nothing here is investment advice; past performance does not
predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard
· PMS leaderboard